SYNB-1353

N/A

Report date: 2023/01/02 21:19:05

Base Information

Drug NameSYNB-1353
Drug Alias NameSYNB-1353 (live biotherapeutic consisting of metP and metDC genes which are incorporated into the genome of a probiotic strain of E. coli Nissie 1917)SYNB1353
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacementsGastrointestinal microbiome modulators
TargetsNot applicable
Therapy Area/IndicationsHomocystinuria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSynlogic Inc
China Registration ClassN/A

Develop Information

Active CompaniesSynlogic IncGinkgo Bioworks Inc
Inactive CompaniesN/A
Active IndicationsHomocystinuria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A